EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
UHAL-B
U-Haul Holding Company
There isn't enough reported data to score UHAL-B yet.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
UHAL-B Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Under pressure |
UHAL-B's profitability is currently healthy, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
UHAL-B PE Valuation
UHAL-B has no meaningful PE right now: it lost money over the past year.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UHAL-B Forward outlook
There aren't enough analyst estimates for UHAL-B to show an outlook.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
UHAL-B Earnings Per Share
UHAL-B has the edge over EOSE in the latest year-over-year earnings comparison.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the stronger quarterly revenue trend. Revenue is up 171% for EOSE versus up 8.7% for UHAL-B.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
UHAL-B Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.8B | +3.1% |
| Q2 2026 | $1.7B | +3.2% |
| Q1 2026 | $1.3B | +3.1% |
| Q3 2025 | $1.7B | +3.7% |
| Q2 2025 | $1.6B | +5.3% |
| Q4 2024 | $1.4B | +3.7% |
| Q3 2024 | $1.7B | +0.5% |
| Q2 2024 | $1.5B | +0.5% |
UHAL-B's revenue has picked up after three years of holding roughly level: $1.8B last quarter, up 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -0.2 points |
| Q2 2026 | 15% | -2.1 points |
| Q1 2026 | -6% | -2.5 points |
| Q3 2025 | 15% | -3.1 points |
| Q2 2025 | 17% | -2.8 points |
| Q1 2025 | -3.5% | N/A |
| Q4 2024 | 11% | -3.9 points |
| Q3 2024 | 18% | -7.4 points |
UHAL-B has the edge over EOSE on profitability, with a higher operating margin.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
UHAL-B has the stronger cash trend. Its trailing FCF is down 19% versus its history, compared with EOSE at down 140%.
UHAL-B Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$342.7M | +$103.7M |
| Q2 2026 | -$192.1M | +$126.1M |
| Q1 2026 | -$147.7M | +$242.8M |
| Q3 2025 | -$446.3M | -$12.8M |
| Q2 2025 | -$318.2M | +$191.1M |
| Q4 2024 | -$664.9M | -$230.9M |
| Q3 2024 | -$433.5M | -$14.4M |
| Q2 2024 | -$509.3M | -$201.4M |
UHAL-B has burned cash in most quarters: −$1.1B over the past year, against −$1.8B the year before.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
UHAL-B Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -1.5M shares |
| 1 year | -0.9% | -1.7M shares |
| 3 years | -0.9% | -1.7M shares |
UHAL-B has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $10.2M |
| Q2 2026 | $15.6M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UHAL-B Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 3.9x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2023 | 2.4x | Moderate |
| Q3 2023 | 2.1x | Moderate |
| Q2 2023 | 1.9x | Healthy |
| Q1 2023 | 1.9x | Healthy |
| Q4 2022 | 2.0x | Healthy |
UHAL-B's net debt is about 3.9 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
UHAL-B Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.1 | Neutral |
| Stochastic | 9.6 | Oversold |
UHAL-B's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
UHAL-B PE vs Industrials Sector
| Metric | UHAL-B | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
UHAL-B has no meaningful PE right now: it lost money over the past year.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
UHAL-B Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $51.1 | 3.5% below |
| 20 week MA | $57.0 | 14% below |
| 50 week MA | $51.9 | 5.2% below |
| 100 week MA | $54.0 | 8.8% below |
| 200 week MA | $56.8 | 13% below |
UHAL-B is in a downtrend: it's below all five of its weekly moving averages, and 13% below its 200-week average.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.
UHAL-B Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $55.9 | $54.9 | -1.9% |
| 2023 | $54.9 | $70.4 | +28% |
| 2024 | $70.4 | $64.2 | -8.9% |
| 2025 | $64.2 | $47.6 | -26% |
| 2026 YTD | $47.6 | $49.3 | +3.4% |
UHAL-B has the edge over EOSE on returns for 2026, with the stronger performance.